Ilofotase alfa, Ilofotase alfa Placebo Drug Product
AP-recAP-CSA-RD-0201
Phase 2 small_molecule active
Quick answer
Ilofotase alfa, Ilofotase alfa Placebo Drug Product for Risk for renal damage following open heart surgery is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Risk for renal damage following open heart surgery
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active